Rise in private testosterone prescribing risks overtreatment and more strain on the NHS
Experts call for national data on private prescriptions to close the evidence gap The rapid expansion of private testosterone prescribing risks extending treatment beyond men with clearly defined need to people with non-specific symptoms and borderline test results, for whom the balance of benefit and long term risk are ...

